AbCellera Biologics, Inc. (ABCL)
10.61
-0.71
(-6.27%)
USD |
NASDAQ |
Aug 24, 16:00
10.94
+0.33
(+3.11%)
Pre-Market: 08:29
AbCellera Biologics Debt to Equity Ratio : 0.1514 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1514 |
| March 31, 2026 | 0.1494 |
| December 31, 2025 | 0.1481 |
| September 30, 2025 | 0.1475 |
| June 30, 2025 | 0.1411 |
| March 31, 2025 | 0.0663 |
| December 31, 2024 | 0.0619 |
| September 30, 2024 | 0.0662 |
| June 30, 2024 | 0.0649 |
| March 31, 2024 | 0.0651 |
| December 31, 2023 | 0.0672 |
| September 30, 2023 | 0.0683 |
| June 30, 2023 | 0.0703 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.0688 |
| December 31, 2022 | 0.0667 |
| September 30, 2022 | 0.0609 |
| June 30, 2022 | 0.0303 |
| March 31, 2022 | 0.0334 |
| December 31, 2021 | 0.0391 |
| September 30, 2021 | 0.0315 |
| June 30, 2021 | 0.0344 |
| March 31, 2021 | 0.0193 |
| December 31, 2020 | 0.0082 |
| September 30, 2020 | 0.0663 |
| June 30, 2020 | 0.2171 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Jazz Pharmaceuticals Plc | 0.9183 |
| Danaher Corp. | 0.5298 |
| Illumina, Inc. | 0.8904 |
| Bio-Techne Corp. | 0.1371 |
| Waters Corp. | 0.3589 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.308B |
| Total Liabilities (Quarterly) | 233.30M |
| Shareholders Equity (Quarterly) | 896.02M |
| Current Ratio | 12.77 |
| Net Debt Paydown Yield | -0.56% |